Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-01

Clinical Trial Update: Effect of Inhaled Aromatherapy on Chemo-Induced Nausea Vomiting (NCVI): CINVAROM (Chemotherapy Induced Nausea Vomiting and AROMatherapy) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating inhaled aromatherapy for chemotherapy-induced nausea and vomiting (CINV) called CINVAROM; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Nausea and Vomiting, Aromatherapy | Phase 2 | Status: COMPLETED